Camcevi Injection, Emulsion
Product Images NDC 69448-023

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Camcevi (NDC 69448-023). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Accord Biopharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel -blister Label (Camcevi Inj Blister Label Terumo Needle)

Principal Display Panel -blister Label (Camcevi Inj Blister Label Terumo Needle)
CAMCEVI 42 mg injectable emulsion pre-filled syringe label. The subcutaneous injection single-dose administration kit contains one sterile 42 mg pre-filled syringe of leuprolide. Labeler is Accord BioPharma, Inc. Storage instructions include refrigeration at 2°C–8°C and protection from light. The product is manufactured in France by Fareva Pau. The label includes dosage and handling instructions for healthcare providers.*
FDA Label Image

Principal Display Panel -carton Label (back) (Camcevi Inj Carton Label 1 Terumo Needle)

Principal Display Panel -carton Label (back) (Camcevi Inj Carton Label 1 Terumo Needle)
An unfolded carton insert for CAMCEVI (leuprolide) subcutaneous injection, emulsion 42 mg/.37g by Accord BioPharma, Inc. The insert includes step-by-step illustrated instructions for syringe assembly, preparing the injection site, administering the treatment, and activating needle safety features. The guide emphasizes proper use of the syringe components and needle protection after injection.*
FDA Label Image

Principal Display Panel -carton Label(front) (Camcevi Inj Carton Label Terumo Needle)

Principal Display Panel -carton Label(front) (Camcevi Inj Carton Label Terumo Needle)
CAMCEVI 42 mg injectable emulsion for subcutaneous injection, presented in a single-dose pre-filled syringe. The packaging indicates the product contains a sterile 42 mg pre-filled syringe and an 18-gauge safety needle. Labeler: Accord BioPharma, Inc. The kit is for administration once every 6 months and includes prescribing information.*
FDA Label Image

Camcevi-inj-figure (Camcevi Inj Figure 1 Terumo Needle)

Camcevi-inj-figure (Camcevi Inj Figure 1 Terumo Needle)
A line graph showing serum testosterone percent change over time in days. The y-axis represents serum testosterone percent change from -100% to above 50%, and the x-axis represents time in days up to 336 days. The graph shows an initial spike above 50%, then a rapid decline near -100%, maintaining this low level throughout the study period. Sample size (N) varies from 137 to 122 across time points shown.*
FDA Label Image

Camcevi-inj-image-2-terumo-needle (Camcevi Inj Image 2 Terumo Needle)

Camcevi-inj-image-2-terumo-needle (Camcevi Inj Image 2 Terumo Needle)
Packaging image of CAMCEVI (leuprolide) injection, emulsion, subcutaneous, showing a prefilled syringe in a sealed blister pack. The product is labeled with a strength of 42 mg/.37 g and is manufactured by Accord BioPharma, Inc. The packaging displays the syringe inside protective clear plastic and foil backing.*
FDA Label Image

Camcevi-inj-image-3-terumo-needle (Camcevi Inj Image 3 Terumo Needle)

Camcevi-inj-image-3-terumo-needle (Camcevi Inj Image 3 Terumo Needle)
An instructional illustration showing two labeled components, A and B. Component A appears to be a prefilled syringe with a plunger, and component B is a device possibly used to assist with injection. The image likely demonstrates parts of the CAMCEVI (leuprolide) subcutaneous injection, emulsion 42 mg/.37g packaging or administration system.*
FDA Label Image

Camcevi-inj-image-4-terumo-needle (Camcevi Inj Image 4 Terumo Needle)

Camcevi-inj-image-4-terumo-needle (Camcevi Inj Image 4 Terumo Needle)
An instructional illustration showing two hands manipulating an injection device labeled as A and B, with curved arrows indicating a twisting or connecting motion. This likely demonstrates a step in the preparation or administration of the CAMCEVI (leuprolide) subcutaneous injection emulsion.*
FDA Label Image

Camcevi-inj-image-5-terumo-needle.jpg (Camcevi Inj Image 5 Terumo Needle)

Camcevi-inj-image-5-terumo-needle.jpg (Camcevi Inj Image 5 Terumo Needle)
An illustration showing a hand pinching the skin, depicting a step in subcutaneous injection technique. The image demonstrates how to properly lift the skin, likely to prepare for an injection.*
FDA Label Image

Camcevi-inj-image-6-terumo-needle (Camcevi Inj Image 6 Terumo Needle)

Camcevi-inj-image-6-terumo-needle (Camcevi Inj Image 6 Terumo Needle)
An instructional diagram showing the removal of an injection cap. One hand is pulling the protective cap from the needle, while the other hand holds the syringe with a downward arrow indicating the cap removal motion.*
FDA Label Image

Camcevi-inj-image-7-terumo-needle (Camcevi Inj Image 7 Terumo Needle)

Camcevi-inj-image-7-terumo-needle (Camcevi Inj Image 7 Terumo Needle)
An instructional illustration showing a hand administering a subcutaneous injection at a 90-degree angle using a syringe. The image depicts the needle inserted into the skin with a drop of liquid visible at the injection site, demonstrating the proper technique for injecting the medication.*
FDA Label Image

Camcevi-inj-image-8-terumo-needle (Camcevi Inj Image 8 Terumo Needle)

Camcevi-inj-image-8-terumo-needle (Camcevi Inj Image 8 Terumo Needle)
Instructional diagram showing a four-step process of preparing a CAMCEVI (leuprolide) injection emulsion for subcutaneous use. The illustrations depict pushing and twisting motions to remove or attach parts, and a click confirmation for securing components, likely related to syringe or needle preparation.*
FDA Label Image

Camcevi-inj-image-9-terumo-needle (Camcevi Inj Image 9 Terumo Needle)

Camcevi-inj-image-9-terumo-needle (Camcevi Inj Image 9 Terumo Needle)
An instructional diagram of a CAMCEVI (leuprolide) injection device showing labeled parts: needle and cover, end stopper, product, barrel, backstop, and plunger rod. The image details components of the subcutaneous injection emulsion delivery system.*
FDA Label Image

Camcevi-inj-structure-terumo-needle (Camcevi Inj Structure Terumo Needle)

Camcevi-inj-structure-terumo-needle (Camcevi Inj Structure Terumo Needle)
Chemical structure diagram of leuprolide, the active ingredient in CAMCEVI injection emulsion, showing its molecular composition with specific details of atoms and bonds, including the presence of CH3SO3H with n values between 1.5 and 1.8.*
FDA Label Image

Principal Display Panel -syringe Label (Camcevi Inj Syringe Label Terumo Needle)

Principal Display Panel -syringe Label (Camcevi Inj Syringe Label Terumo Needle)
Label for CAMCEVI (leuprolide) injectable emulsion, 42 mg single-dose pre-filled syringe for subcutaneous injection only. Manufactured by Accord BioPharma, Inc., Raleigh, NC. Label includes NDC 69448-023-63, barcode, Rx only, and areas for expiration date and lot number.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.